Search Results - Matthieu Allez
- Showing 1 - 11 results of 11
-
1
KLRG1 and CD103 Expressions Define Distinct Intestinal Tissue-Resident Memory CD8 T Cell Subsets Modulated in Crohn's Disease by Hugo Bottois, Marjolaine Ngollo, Nassim Hammoudi, Nassim Hammoudi, Tristan Courau, Julie Bonnereau, Victor Chardiny, Céline Grand, Brice Gergaud, Matthieu Allez, Matthieu Allez, Lionel Le Bourhis
Published in Frontiers in Immunology (2020-05-01)Get full text
Article -
2
Critical Contribution of NK Group 2 Member D Expressed on Invariant Natural Killer T Cells in Concanavalin A-Induced Liver Hepatitis in Mice by Dina Al Dulaimi, Dina Al Dulaimi, Jihene Klibi, Jihene Klibi, Veronica Olivo Pimentel, Veronica Olivo Pimentel, Veronique Parietti, Veronique Parietti, Matthieu Allez, Matthieu Allez, Antoine Toubert, Antoine Toubert, Kamel Benlagha, Kamel Benlagha
Published in Frontiers in Immunology (2018-05-01)Get full text
Article -
3
A Genetic Association Test Accounting for Skewed X-Inactivation With Application to Biotherapy Immunogenicity in Patients With Autoimmune Diseases by Signe Hässler, Signe Hässler, Sophie Camilleri-Broët, Matthieu Allez, Florian Deisenhammer, Anna Fogdell-Hahn, Xavier Mariette, Marc Pallardy, Philippe Broët
Published in Frontiers in Medicine (2022-06-01)Get full text
Article -
4
Epigenetic master regulators HDAC1 and HDAC5 control pathobiont Enterobacteria colonization in ileal mucosa of Crohn’s disease patients by Mélissa Chervy, Adeline Sivignon, Flavie Dambrine, Anthony Buisson, Pierre Sauvanet, Catherine Godfraind, Matthieu Allez, Lionel Le Bourhis, The Remind Group, Nicolas Barnich, Jérémy Denizot
Published in Gut Microbes (2022-12-01)Get full text
Article -
5
Cocultures of human colorectal tumor spheroids with immune cells reveal the therapeutic potential of MICA/B and NKG2A targeting for cancer treatment by Tristan Courau, Julie Bonnereau, Justine Chicoteau, Hugo Bottois, Romain Remark, Laura Assante Miranda, Antoine Toubert, Mathieu Blery, Thomas Aparicio, Matthieu Allez, Lionel Le Bourhis
Published in Journal for ImmunoTherapy of Cancer (2019-03-01)Get full text
Article -
6
Assessing the effect of genetic markers on drug immunogenicity from a mechanistic model-based approach by Julianne Duhazé, Miguel Caubet, Signe Hässler, Delphine Bachelet, Matthieu Allez, Florian Deisenhammer, Anna Fogdell-Hahn, Aude Gleizes, Salima Hacein-Bey-Abina, Xavier Mariette, Marc Pallardy, Philippe Broët, on behalf of the ABIRISK Consortium
Published in BMC Medical Research Methodology (2020-03-01)Get full text
Article -
7
Specific IgG response against Mycobacterium avium paratuberculosis in children and adults with Crohn's disease. by Julien Verdier, Louis Deroche, Matthieu Allez, Caroline Loy, Franck Biet, Christelle C Bodier, Sylvie Bay, Christelle Ganneau, Tamara Matysiak-Budnik, Jean Marc Reyrat, Martine Heyman, Nadine Cerf-Bensussan, Frank M Ruemmele, Sandrine Ménard
Published in PLoS ONE (2013-01-01)Get full text
Article -
8
Diet prevents the expansion of segmented filamentous bacteria and ileo-colonic inflammation in a model of Crohn’s disease by Amira Metwaly, Jelena Jovic, Nadine Waldschmitt, Sevana Khaloian, Helena Heimes, Deborah Häcker, Mohamed Ahmed, Nassim Hammoudi, Lionel Le Bourhis, Aida Mayorgas, Kolja Siebert, Marijana Basic, Tobias Schwerd, Matthieu Allez, Julian Panes, Azucena Salas, André Bleich, Sebastian Zeissig, Pamela Schnupf, Fabio Cominelli, Dirk Haller
Published in Microbiome (2023-03-01)Get full text
Article -
9
Fecal microbiota and bile acids in IBD patients undergoing screening for colorectal cancer by Aonghus Lavelle, Stéphane Nancey, Jean-Marie Reimund, David Laharie, Philippe Marteau, Xavier Treton, Matthieu Allez, Xavier Roblin, Georgia Malamut, Cyriane Oeuvray, Nathalie Rolhion, Xavier Dray, Dominique Rainteau, Antonin Lamaziere, Emilie Gauliard, Julien Kirchgesner, Laurent Beaugerie, Philippe Seksik, Laurent Peyrin-Biroulet, Harry Sokol
Published in Gut Microbes (2022-12-01)Get full text
Article -
10
The risk of COVID-19 in IBD patients is increased by urban living and is not influenced by disease activity or intravenous biologics by Margaux Lelong, Régis Josien, Régis Josien, Marianne Coste-Burel, Marie Rimbert, Céline Bressollette-Bodin, Céline Bressollette-Bodin, Stéphane Nancey, Guillaume Bouguen, Matthieu Allez, Mélanie Serrero, Ludovic Caillo, Cléa Rouillon, Pierre Blanc, David Laharie, Raphaël Olivier, Laurent Peyrin-Biroulet, Nina Dib, Astrid De Maissin, Céline Montuclard, Caroline Trang-Poisson, Fabienne Vavasseur, Géraldine Gallot, Mathilde Berthome, Cécile Braudeau, Cécile Braudeau, Justine Chevreuil, Arnaud Bourreille, Catherine Le Berre
Published in Frontiers in Immunology (2023-08-01)Get full text
Article -
11
Guselkumab binding to CD64+ IL-23–producing myeloid cells enhances potency for neutralizing IL-23 signaling by Kacey L. Sachen, Deepa Hammaker, Indra Sarabia, Brian Stoveken, John Hartman, Kristin L. Leppard, Nicholas A. Manieri, Phuc Bao, Carrie Greving, Eilyn R. Lacy, Matthew DuPrie, Joshua Wertheimer, Janise D. Deming, Joseph Brown, Amy Hart, He (Hurley) Li, Tom C. Freeman, Brice Keyes, Kristen Kohler, Ian White, Nathan Karpowich, Ruth Steele, M. Merle Elloso, Steven Fakharzadeh, Kavitha Goyal, Frédéric Lavie, Maria T. Abreu, Matthieu Allez, Raja Atreya, Robert Bissonnette, Kilian Eyerich, Kilian Eyerich, James G. Krueger, Dennis McGonagle, Iain B. McInnes, Christopher Ritchlin, Anne M. Fourie
Published in Frontiers in Immunology (2025-03-01)Get full text
Article
